Pharsight

Drugs that contain Levalbuterol Tartrate

1. Xopenex Hfa patents expiration

XOPENEX HFA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7256310 LUPIN Levalbuterol salt
Oct, 2024

(5 months from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5362755 LUPIN Method for treating asthma using optically pure (R)-albuterol
Mar, 2013

(11 years ago)

US5547994 LUPIN Method for treating asthma using optically pure R(-) albuterol
Aug, 2013

(10 years ago)

US5605674 LUPIN Medicinal aerosol formulations
Feb, 2014

(10 years ago)

US5836299 LUPIN Seals for use in an aerosol delivery device
Nov, 2015

(8 years ago)

US8765153 LUPIN Levalbuterol salt
Dec, 2023

(4 months ago)

Drug Exclusivity Drug Exclusivity Expiration
M(M-156) Mar 12, 2018

Market Authorisation Date: 11 March, 2005

Treatment: Treatment or prevention of bronchospasm or asthmatic symptoms

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of XOPENEX HFA before it's drug patent expiration?
More Information on Dosage

XOPENEX HFA family patents

Family Patents